Literature DB >> 12652467

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.

Geoffrey W Chan1, Gullu Gorgun, Kenneth B Miller, Francine M Foss.   

Abstract

Graft-versus-host disease (GVHD) causes significant morbidity and mortality in patients undergoing allogeneic bone marrow transplantation following either a conventional or reduced-intensity preparative regimen. In a murine model, inactivation of host dendritic cells (DCs) was associated with a significant reduction in acute GVHD, suggesting that host DCs may play an important role in the pathogenesis of acute GVHD. The role of host DCs in the development of GVHD following allogeneic stem cell transplantation in humans, however, is unclear. We examined DC chimerism in patients with various hematologic malignancies who underwent a reduced-intensity preparative regimen of extracorporeal photophoresis, pentostatin, and reduced-dose total body irradiation (n = 21) or a conventional preparative regimen of cyclophosphamide and total body irradiation (n = 3). Full donor hematopoietic reconstitution was demonstrated in 19 of 21 patients who underwent a reduced-intensity preparative regimen and in all patients who underwent a conventional preparative regimen. Grade 0 to I acute GVHD and limited or no chronic GVHD were observed in 18 patients who underwent a reduced-intensity regimen and 1 patient who underwent a conventional regimen who achieved full donor DC chimerism at day +100 posttransplantation. In contrast, grade II to IV acute GVHD and extensive chronic GVHD were observed in the 2 patients who underwent a conventional regimen and the 1 patient who underwent a reduced-intensity regimen who had host rather than donor DC chimerism. The persistence of host DCs at day +100 posttransplantation is correlated with the development of severe acute and chronic GVHD (P =.001). Host DCs may represent a therapeutic target for reducing GVHD in allogeneic bone marrow transplants. Copyright 2003 American Society for Blood and Marrow Transplantation

Entities:  

Mesh:

Year:  2003        PMID: 12652467     DOI: 10.1053/bbmt.2003.50006

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  20 in total

1.  Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Authors:  Qing Ma; Dan Li; Roza Nurieva; Rebecca Patenia; Roland Bassett; Wei Cao; Andrei M Alekseev; Hong He; Jeffrey J Molldrem; Michael H Kroll; Richard E Champlin; George E Sale; Vahid Afshar-Kharghan
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-01       Impact factor: 5.742

Review 2.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

Review 3.  The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.

Authors:  Hong-Gang Ren; Djamilatou Adom; Sophie Paczesny
Journal:  Expert Rev Clin Immunol       Date:  2018-04-19       Impact factor: 4.473

Review 4.  State-of-the-art acute and chronic GVHD treatment.

Authors:  Muhammad Omer Jamil; Shin Mineishi
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

5.  Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs.

Authors:  Hemn Mohammadpour; Rachel O'Neil; Jingxin Qiu; Philip L McCarthy; Elizabeth A Repasky; Xuefang Cao
Journal:  J Immunol       Date:  2018-02-14       Impact factor: 5.422

Review 6.  Reconstructing immunity after allogeneic transplantation.

Authors:  Cynthia R Giver; Jian-Ming Li; Mohammad S Hossain; Sagar Lonial; Edmund K Waller
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 7.  Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

Authors:  J J Auletta; S M Devine; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

8.  High-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host disease.

Authors:  Ryan Remy Brinkman; Maura Gasparetto; Shang-Jung Jessica Lee; Albert J Ribickas; Janelle Perkins; William Janssen; Renee Smiley; Clay Smith
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-06       Impact factor: 5.742

9.  Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Authors:  P J Shaughnessy; B J Bolwell; K van Besien; M Mistrik; A Grigg; A Dodds; H M Prince; S Durrant; O Ilhan; D Parenti; J Gallo; F Foss; J Apperley; M-J Zhang; M M Horowitz; S Abhyankar
Journal:  Bone Marrow Transplant       Date:  2009-11-16       Impact factor: 5.483

Review 10.  Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.